These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29065822)

  • 81. Lanthanide complexes containing 5-methyl-1,2,4-triazolo[1,5-a] pyrimidin-7(4H)-one and their therapeutic potential to fight leishmaniasis and Chagas disease.
    Caballero AB; Rodríguez-Diéguez A; Salas JM; Sánchez-Moreno M; Marín C; Ramírez-Macías I; Santamaría-Díaz N; Gutiérrez-Sánchez R
    J Inorg Biochem; 2014 Sep; 138():39-46. PubMed ID: 24861807
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Synthesis of quinones with highlighted biological applications: A critical update on the strategies towards bioactive compounds with emphasis on lapachones.
    da Silva Júnior EN; Jardim GAM; Jacob C; Dhawa U; Ackermann L; de Castro SL
    Eur J Med Chem; 2019 Oct; 179():863-915. PubMed ID: 31306817
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Neglected tropical diseases: multi-target-directed ligands in the search for novel lead candidates against Trypanosoma and Leishmania.
    Cavalli A; Bolognesi ML
    J Med Chem; 2009 Dec; 52(23):7339-59. PubMed ID: 19606868
    [No Abstract]   [Full Text] [Related]  

  • 84. Editorial: medicinal chemistry studies of neglected diseases.
    Scotti L; Scotti MT
    Mini Rev Med Chem; 2015; 15(3):180-1. PubMed ID: 25769966
    [No Abstract]   [Full Text] [Related]  

  • 85. Prodrugs for the treatment of neglected diseases.
    Chung MC; Ferreira EI; Santos JL; Giarolla J; Rando DG; Almeida AE; Bosquesi PL; Menegon RF; Blau L
    Molecules; 2007 Mar; 13(3):616-77. PubMed ID: 18463559
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Folates in Trypanosoma brucei: Achievements and Opportunities.
    Cullia G; Tamborini L; Conti P; De Micheli C; Pinto A
    ChemMedChem; 2018 Oct; 13(20):2150-2158. PubMed ID: 30152195
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [International Partnership for Therapeutic Drug Development of NTDs by DNDi].
    Yamada H; Hirabayashi F; Brünger C
    Yakugaku Zasshi; 2016; 136(2):213-22. PubMed ID: 26831796
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Contemporary strategies and methods of modeling antiparasitic drugs].
    Boczoń K
    Wiad Parazytol; 1995; 41(1):43-52. PubMed ID: 7638963
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Polyamines and Related Nitrogen Compounds in the Chemotherapy of Neglected Diseases Caused by Kinetoplastids.
    Bisceglia JA; Mollo MC; Gruber N; Orelli LR
    Curr Top Med Chem; 2018; 18(5):321-368. PubMed ID: 29701142
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Finding new hits in neglected disease projects: target or phenotypic based screening?
    Gilbert IH; Leroy D; Frearson JA
    Curr Top Med Chem; 2011; 11(10):1284-91. PubMed ID: 21401505
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Alternative Host Models for Testing Anti-Protozoal or Antifungal Compounds and Fungal Infection.
    Torrecilhas AC; Xander P; Ferreira KS; Batista WL
    Curr Top Med Chem; 2018; 18(4):300-311. PubMed ID: 29651932
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Progresses in the field of drug design to combat tropical protozoan parasitic diseases.
    Liñares GE; Ravaschino EL; Rodriguez JB
    Curr Med Chem; 2006; 13(3):335-60. PubMed ID: 16475941
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Bis(2-aminoimidazolines) and Bisguanidines: Synthetic Approaches, Antiparasitic Activity and DNA Binding Properties.
    Dardonville C; Martínez JJN
    Curr Med Chem; 2017; 24(33):3606-3632. PubMed ID: 28641558
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Synthesis and in vitro antiprotozoal evaluation of substituted phenalenone analogues.
    Rosquete LI; Cabrera-Serra MG; Piñero JE; Martín-Rodríguez P; Fernández-Pérez L; Luis JG; McNaughton-Smith G; Abad-Grillo T
    Bioorg Med Chem; 2010 Jun; 18(12):4530-4. PubMed ID: 20472446
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Bioactive Natural and Synthetic Peroxides for the Treatment of Helminth and Protozoan Pathogens: Synthesis and Properties.
    Vil' VA; Terent'ev AO; Mulina OM
    Curr Top Med Chem; 2019; 19(14):1201-1225. PubMed ID: 31509099
    [TBL] [Abstract][Full Text] [Related]  

  • 96. In vitro antiplasmodial, antitrypanosomal and antileishmanial activities of selected medicinal plants from Ugandan flora: Refocusing into multi-component potentials.
    Obbo CJD; Kariuki ST; Gathirwa JW; Olaho-Mukani W; Cheplogoi PK; Mwangi EM
    J Ethnopharmacol; 2019 Jan; 229():127-136. PubMed ID: 30273736
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Novel compounds to combat trypanosomatid infections: a medicinal chemical perspective.
    González M; Cerecetto H
    Expert Opin Ther Pat; 2011 May; 21(5):699-715. PubMed ID: 21428846
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Protozoan Parasites Glycosylphosphatidylinositol Anchors: Structures, Functions and Trends for Drug Discovery.
    Morotti ALM; Martins-Teixeira MB; Carvalho I
    Curr Med Chem; 2019; 26(23):4301-4322. PubMed ID: 28748758
    [TBL] [Abstract][Full Text] [Related]  

  • 99. SAR studies on azasterols as potential anti-trypanosomal and anti-leishmanial agents.
    Gigante F; Kaiser M; Brun R; Gilbert IH
    Bioorg Med Chem; 2009 Aug; 17(16):5950-61. PubMed ID: 19620005
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Unpacking the Pathogen Box-An Open Source Tool for Fighting Neglected Tropical Disease.
    Veale CGL
    ChemMedChem; 2019 Feb; 14(4):386-453. PubMed ID: 30614200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.